Trial Outcomes & Findings for Changing the Default for Tobacco Treatment (NCT NCT02721082)

NCT ID: NCT02721082

Last Updated: 2022-12-01

Results Overview

7-day, self-reported and verified cigarette abstinence.

Recruitment status

COMPLETED

Study phase

PHASE4

Target enrollment

1000 participants

Primary outcome timeframe

Month 1

Results posted on

2022-12-01

Participant Flow

Participant milestones

Participant milestones
Measure
Opt Out
Participants in this arm will be first enrolled to receive cessation treatment and will only not receive it by "opting out". Participant will receive a Opt Out treatment program. Participants will receive counseling and nicotine replacement therapy. Opt Out Treatment Program: Tobacco Treatment (UKanQuit) staff will complete a treatment plan for all participants. Nicotine Replacement Therapy: Unless they Opt Out all participants will be provided with a 14 day supply of the nicotine patch and nicotine mini-lozenges or nicotine gum, depending on study related criteria.
Opt In
Traditional approach to tobacco treatment program. Participants must first indicate they are ready to quit smoking by "opting in" to receive Opt In treatment program. Opt In Treatment Program: Tobacco Treatment (UKanQuit) staff will complete a treatment plan for participant's who are ready to quit smoking. For patient's not ready to quit, motivational counseling will be provided to participants based on principles of Motivational Interviewing. Nicotine Replacement Therapy: Participants ready to quit will be provided with a 14 day supply of the nicotine patch and nicotine mini-lozenges or nicotine gum, depending on study related criteria.
Overall Study
STARTED
655
345
Overall Study
COMPLETED
469
270
Overall Study
NOT COMPLETED
186
75

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Changing the Default for Tobacco Treatment

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Opt Out
n=469 Participants
Participants in this arm will be first enrolled to receive cessation treatment and will only not receive it by "opting out". Participant will receive a Opt Out treatment program. Participants will receive counseling and nicotine replacement therapy. Opt Out Treatment Program: Tobacco Treatment (UKanQuit) staff will complete a treatment plan for all participants. Nicotine Replacement Therapy: Unless they Opt Out all participants will be provided with a 14 day supply of the nicotine patch and nicotine mini-lozenges or nicotine gum, depending on study related criteria.
Opt In
n=270 Participants
Traditional approach to tobacco treatment program. Participants must first indicate they are ready to quit smoking by "opting in" to receive Opt In treatment program. Opt In Treatment Program: Tobacco Treatment (UKanQuit) staff will complete a treatment plan for participant's who are ready to quit smoking. For patient's not ready to quit, motivational counseling will be provided to participants based on principles of Motivational Interviewing. Nicotine Replacement Therapy: Participants ready to quit will be provided with a 14 day supply of the nicotine patch and nicotine mini-lozenges or nicotine gum, depending on study related criteria.
Total
n=739 Participants
Total of all reporting groups
Age, Continuous
51.21 years
STANDARD_DEVIATION 14.80 • n=5 Participants
51.70 years
STANDARD_DEVIATION 14.56 • n=7 Participants
51.39 years
STANDARD_DEVIATION 14.71 • n=5 Participants
Sex: Female, Male
Female
226 Participants
n=5 Participants
123 Participants
n=7 Participants
349 Participants
n=5 Participants
Sex: Female, Male
Male
243 Participants
n=5 Participants
147 Participants
n=7 Participants
390 Participants
n=5 Participants
Race/Ethnicity, Customized
Non-Hispanic White
270 Participants
n=5 Participants
158 Participants
n=7 Participants
428 Participants
n=5 Participants
Race/Ethnicity, Customized
Non-Hispanic Black
83 Participants
n=5 Participants
49 Participants
n=7 Participants
132 Participants
n=5 Participants
Race/Ethnicity, Customized
Non-Hispanic multiracial
75 Participants
n=5 Participants
51 Participants
n=7 Participants
126 Participants
n=5 Participants
Race/Ethnicity, Customized
Hispanic
32 Participants
n=5 Participants
11 Participants
n=7 Participants
43 Participants
n=5 Participants
Region of Enrollment
United States
469 participants
n=5 Participants
270 participants
n=7 Participants
739 participants
n=5 Participants

PRIMARY outcome

Timeframe: Month 1

Population: We calculated the Bayesian Posterior Probability (BPP) and Bayesian 95% Credible Intervals for all outcomes. ClinicalTrials.gov has no option to select these, so the labels for the credible intervals will appear as "confidence intervals"

7-day, self-reported and verified cigarette abstinence.

Outcome measures

Outcome measures
Measure
Opt Out
n=469 Participants
Participants in this arm will be first enrolled to receive cessation treatment and will only not receive it by "opting out". Participant will receive a Opt Out treatment program. Participants will receive counseling and nicotine replacement therapy. Opt Out Treatment Program: Tobacco Treatment (UKanQuit) staff will complete a treatment plan for all participants. Nicotine Replacement Therapy: Unless they Opt Out all participants will be provided with a 14 day supply of the nicotine patch and nicotine mini-lozenges or nicotine gum, depending on study related criteria.
Opt In
n=270 Participants
Traditional approach to tobacco treatment program. Participants must first indicate they are ready to quit smoking by "opting in" to receive Opt In treatment program. Opt In Treatment Program: Tobacco Treatment (UKanQuit) staff will complete a treatment plan for participant's who are ready to quit smoking. For patient's not ready to quit, motivational counseling will be provided to participants based on principles of Motivational Interviewing. Nicotine Replacement Therapy: Participants ready to quit will be provided with a 14 day supply of the nicotine patch and nicotine mini-lozenges or nicotine gum, depending on study related criteria.
7-day Point-prevalence Abstinence
21.5 Percentage of participants quit at 1-mo
Interval 17.9 to 25.4
15.8 Percentage of participants quit at 1-mo
Interval 11.8 to 20.5

SECONDARY outcome

Timeframe: Month 1

Population: Accepted a post-discharge script for medication

Percentages of participants who use cessation medications and participate in counseling post discharge

Outcome measures

Outcome measures
Measure
Opt Out
n=469 Participants
Participants in this arm will be first enrolled to receive cessation treatment and will only not receive it by "opting out". Participant will receive a Opt Out treatment program. Participants will receive counseling and nicotine replacement therapy. Opt Out Treatment Program: Tobacco Treatment (UKanQuit) staff will complete a treatment plan for all participants. Nicotine Replacement Therapy: Unless they Opt Out all participants will be provided with a 14 day supply of the nicotine patch and nicotine mini-lozenges or nicotine gum, depending on study related criteria.
Opt In
n=270 Participants
Traditional approach to tobacco treatment program. Participants must first indicate they are ready to quit smoking by "opting in" to receive Opt In treatment program. Opt In Treatment Program: Tobacco Treatment (UKanQuit) staff will complete a treatment plan for participant's who are ready to quit smoking. For patient's not ready to quit, motivational counseling will be provided to participants based on principles of Motivational Interviewing. Nicotine Replacement Therapy: Participants ready to quit will be provided with a 14 day supply of the nicotine patch and nicotine mini-lozenges or nicotine gum, depending on study related criteria.
Treatment Engagement
87.68 Percentage of participants w/script
Interval 84.5 to 90.54
37.84 Percentage of participants w/script
Interval 32.18 to 43.75

SECONDARY outcome

Timeframe: Month 1

Population: BPP and credible intervals

We will assess the impact of opt-out versus opt-in treatment on perceived treatment coercion using items adapted from the Admission Experience Survey (AES) short form.

Outcome measures

Outcome measures
Measure
Opt Out
n=469 Participants
Participants in this arm will be first enrolled to receive cessation treatment and will only not receive it by "opting out". Participant will receive a Opt Out treatment program. Participants will receive counseling and nicotine replacement therapy. Opt Out Treatment Program: Tobacco Treatment (UKanQuit) staff will complete a treatment plan for all participants. Nicotine Replacement Therapy: Unless they Opt Out all participants will be provided with a 14 day supply of the nicotine patch and nicotine mini-lozenges or nicotine gum, depending on study related criteria.
Opt In
n=270 Participants
Traditional approach to tobacco treatment program. Participants must first indicate they are ready to quit smoking by "opting in" to receive Opt In treatment program. Opt In Treatment Program: Tobacco Treatment (UKanQuit) staff will complete a treatment plan for participant's who are ready to quit smoking. For patient's not ready to quit, motivational counseling will be provided to participants based on principles of Motivational Interviewing. Nicotine Replacement Therapy: Participants ready to quit will be provided with a 14 day supply of the nicotine patch and nicotine mini-lozenges or nicotine gum, depending on study related criteria.
Default-theory Based Measures
88.41 % felt they had control over quitting
Interval 85.19 to 91.28
86.64 % felt they had control over quitting
Interval 82.07 to 90.63

SECONDARY outcome

Timeframe: Month 6

7-day, self-reported and verified cigarette abstinence.

Outcome measures

Outcome measures
Measure
Opt Out
n=469 Participants
Participants in this arm will be first enrolled to receive cessation treatment and will only not receive it by "opting out". Participant will receive a Opt Out treatment program. Participants will receive counseling and nicotine replacement therapy. Opt Out Treatment Program: Tobacco Treatment (UKanQuit) staff will complete a treatment plan for all participants. Nicotine Replacement Therapy: Unless they Opt Out all participants will be provided with a 14 day supply of the nicotine patch and nicotine mini-lozenges or nicotine gum, depending on study related criteria.
Opt In
n=270 Participants
Traditional approach to tobacco treatment program. Participants must first indicate they are ready to quit smoking by "opting in" to receive Opt In treatment program. Opt In Treatment Program: Tobacco Treatment (UKanQuit) staff will complete a treatment plan for participant's who are ready to quit smoking. For patient's not ready to quit, motivational counseling will be provided to participants based on principles of Motivational Interviewing. Nicotine Replacement Therapy: Participants ready to quit will be provided with a 14 day supply of the nicotine patch and nicotine mini-lozenges or nicotine gum, depending on study related criteria.
7-day Point-prevalence Abstinence
18.57 Percentage of participants quit at 6-mo
Interval 15.0 to 22.4
17.90 Percentage of participants quit at 6-mo
Interval 13.2 to 23.1

OTHER_PRE_SPECIFIED outcome

Timeframe: Month 6

Counselor time, wage estimates, pharmacotherapy costs, and abstinence rates will be combined to report the incremental cost-effective ratio (ICER). The ICER is the ratio of the difference in costs divided by the difference in effectiveness between the two study arms. ICER indicates the added cost per additional quitter, a metric that will allow comparisons to other smoking cessation economic studies.

Outcome measures

Outcome data not reported

Adverse Events

Opt Out

Serious events: 191 serious events
Other events: 0 other events
Deaths: 27 deaths

Opt In

Serious events: 89 serious events
Other events: 0 other events
Deaths: 19 deaths

Serious adverse events

Serious adverse events
Measure
Opt Out
n=655 participants at risk
Participants in this arm will be first enrolled to receive cessation treatment and will only not receive it by "opting out". Participant will receive a Opt Out treatment program. Participants will receive counseling and nicotine replacement therapy. Opt Out Treatment Program: Tobacco Treatment (UKanQuit) staff will complete a treatment plan for all participants. Nicotine Replacement Therapy: Unless they Opt Out all participants will be provided with a 14 day supply of the nicotine patch and nicotine mini-lozenges or nicotine gum, depending on study related criteria.
Opt In
n=345 participants at risk
Traditional approach to tobacco treatment program. Participants must first indicate they are ready to quit smoking by "opting in" to receive Opt In treatment program. Opt In Treatment Program: Tobacco Treatment (UKanQuit) staff will complete a treatment plan for participant's who are ready to quit smoking. For patient's not ready to quit, motivational counseling will be provided to participants based on principles of Motivational Interviewing. Nicotine Replacement Therapy: Participants ready to quit will be provided with a 14 day supply of the nicotine patch and nicotine mini-lozenges or nicotine gum, depending on study related criteria.
General disorders
Death, Hospitalization, or Life threatening illness
29.2%
191/655 • Number of events 191 • Adverse event data were collect for 6 months following randomization
Definitions do not differ from those of clinicaltrials.gov
25.8%
89/345 • Number of events 89 • Adverse event data were collect for 6 months following randomization
Definitions do not differ from those of clinicaltrials.gov

Other adverse events

Adverse event data not reported

Additional Information

Dr. Kimber Richter

U. Kansas Medical Center

Phone: 9134490157

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place